arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Syndax Pharmaceuticals, Inc.

SNDX Health Care Biotechnology: Pharmaceutical Preparations
$17.34
▼ -3.8% Today
as of Jun 7, 07:28 ET
Last 30 days -17.86% Apr 28 → Jun 05
$17.01 $18.21 $19.41 $20.62 $21.82 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$18.13
High
$18.13
Low
$17.11
Volume
$3M
Avg Vol
$2M
Mkt Cap
$1.7B
P/E (TTM)
Beta
52w High
$25.59
52w Low
$8.59
Div Yield
Shares Out
$89M

Overview

52-week range
$8.59
$26
51% of range
Avg surprise (last 1)
+5.8%
Avg reaction (last 1)
-1.2%
0% positive
Latest IV / EM
112%
EM ±15.6% · $17 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.04$-0.90$-0.76$-0.62$-0.48 Actual $-0.64Actual $-0.73Actual $-0.85Actual $-0.80Actual $-0.98Actual $-0.98Est $-1.04Actual $-0.83Actual $-0.70Actual $-0.48 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$-85M$-47M$-8M$30M$68M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $-0.48 financials
Tue Sep 30, 2025Sep 2025 $-0.70 financials
Mon Jun 30, 2025Jun 2025 $-0.83 financials
Mon May 5, 2025Mar/2025 $-0.98 $-1.04 +5.8% -1.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.98 financials
Sun Jun 30, 2024Jun 2024 $-0.80 financials
Sun Mar 31, 2024Mar 2024 $-0.85 financials
Sat Sep 30, 2023Sep 2023 $-0.73 financials
Fri Jun 30, 2023Jun 2023 $-0.64 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$65M$46M$38M$20M$12M$4M
Cost of revenue
Gross profit
Operating income$-34M$-57M$-69M$-84M$-90M$-74M
Net income$-43M$-61M$-72M$-85M$-84M$-68M
EPS (diluted)$-0.48$-0.70$-0.83$-0.98$-0.98$-0.80

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$131M$135M$117M$109M$154M$154M$133M$105M
Inventory$35M$33M$25M$18M$5M$366,000
Total current assets$471M$528M$530M$532M$549M$603M$415M$446M
Total assets$473M$530M$552M$596M$641M$725M$426M$477M
Long-term debt
Total liabilities$431M$465M$436M$439M$426M$437M$59M$43M
Total equity$42M$65M$115M$157M$215M$288M$366M$434M

Implied volatility — last 90 days

107%109%112%114%117% Jun 07 — IV 112% · EM ±15.6%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.